On Feb. 12, Stephanie Protze, a scientist at the McEwen Stem Cell Institute, University Health Network (UHN), and a Medicine by Design New Investigator, appeared on CTV News to speak about her biological pacemaker research with anchor and reporter Angie Seth.
Protze’s research focuses on biological pacemaker cells, which can cause the heart to have a too slow rhythm when they are damaged.
“Our goal is to replace these damaged cells with new functional cells to create the first biological pacemaker that then functions without the wires and batteries that an electronic pacemaker requires, and potentially could be a lifelong cure for patients with pacemaker issues,” she said.
Protze joined the University Health Network and University of Toronto (U of T) in 2018 in a recruitment supported by Medicine by Design. In addition to her primary UHN appointment, Protze is an assistant professor in the Department of Molecular Genetics at U of T.
Watch the full interview on CTV
About Medicine by Design and regenerative medicine
Medicine by Design builds on decades of made-in-Canada excellence in regenerative medicine dating back to the discovery of stem cells in the early 1960s by Toronto researchers James Till and Dr. Ernest McCulloch. Medicine by Design is made possible thanks in part to a $114-million grant from the Canada First Research Excellence Fund.
Regenerative medicine uses stem cells to replace diseased tissues and organs, creating therapies in which cells are the biological product. It can also mean triggering stem cells that are already present in the human body to repair damaged tissues or to modulate immune responses. Increasingly, regenerative medicine researchers are using a stem cell lens to identify critical interactions or defects that prepare the ground for disease, paving the way for new approaches to preventing disease before it starts.